Categories: HospitalsNews

InventHelp Inventor Develops Multiple IV Identifying Device (BKC-692)

PITTSBURGH, Nov. 28, 2025 /PRNewswire/ — “As a registered nurse, I thought there could be an easier way to care for patients receiving multiple IV medications,” said an inventor, from Nashua, N.H., “so I invented the MED-TRAXX. My design enables you to easily ascertain which medication is running into which port, and it could help prevent medication errors.”

The patent-pending invention provides a new device that would help eliminate errors when administering multiple IV medications. In doing so, it allows nurses to identify IV drip medications at a glance. As a result, it increases safety, accuracy, and convenience. It also would help prevent tangled IV lines and tugging. The invention features a simple design that is easy to use so it is ideal for hospitals and medical facilities.

The original design was submitted to the Boston sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-BKC-692, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp’s Invention Submission Services at http://www.InventHelp.com.  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inventhelp-inventor-develops-multiple-iv-identifying-device-bkc-692-302622862.html

SOURCE InventHelp

Staff

Recent Posts

Owlet Launches TGA-Approved Dream Sock™ in Australia & New Zealand, Expanding International Footprint and Bringing Trusted Pediatric Health Monitoring to More Families Worldwide

TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription…

2 hours ago

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

Concludes Distribution Agreement with Gore® for VIABIL® in the United States and Canada, Effective January…

2 hours ago

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company…

2 hours ago

Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025

Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the…

2 hours ago